Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction

🔗 Access full article via RSC Medicinal Chemistry

RSC Medicine Advance Article, 2023, Chem.
DOI: 10.1039/D3MD00137G, Research ArticleOpen access.&nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Samuel Y. Boateng, Francesca Greco, Helen M. I. Osborn, and Madonna Ma. A. Mitry.
Based on the Staudinger ligation bioorthogonal reaction, a novel and targeted prodrug system for breast cancer is described.
Use the DOI form of citation to cite this article before assigning page numbers.
The Royal Society of Chemistry’s RSS Feed( c ) content